Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Delta Air Lines, Atara Biotherapeutics, and Skyworks Solutions Slumped Today

By Dan Caplinger - Updated Apr 11, 2019 at 9:02PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out what made these high-flying stocks lose altitude.

Wall Street saw negative sentiment return in a big way on Thursday, powering the Dow Jones Industrial Average to a loss of more than 600 points. Despite all the attention that one key player in the tech sector got, declines were spread out across the market, and investors seemed worried overall about the potential for a global economic slowdown that could bring the long bull market in the U.S. to a halt once and for all. Several high-profile stocks suffered big drops, and Delta Air Lines ( DAL 7.50% ), Atara Biotherapeutics ( ATRA -0.82% ), and Skyworks Solutions ( SWKS 1.80% ) were among the worst performers. Here's why they did so poorly.

Delta sinks on weaker outlook

Shares of Delta Air Lines finished 9% lower after the airline giant reported its operating performance for December and also gave an early look at fourth-quarter financial projections. The carrier said it had a record 15.3 million customers during the month, but investors seemed dissatisfied with Delta's prediction for adjusted earnings of between $1.25 and $1.30 per share, despite it being close to the consensus forecast among those following the stock. Delta did cut its growth estimate for revenue per available seat mile by half a percentage point to 3%, however, and that stoked fears that 2019 might not be as strong a recovery year as some were hoping.

Check out the latest Delta Air Lines earnings call transcript.

White airplane with Delta markings on a clean tarmac under a dark overcast sky near sunset.

Image source: Delta Air Lines.

Atara makes a CEO move

Atara Biotherapeutics saw its stock plunge more than 19% following news that the company will lose its current chief executive officer. CEO Isaac Ciechanover will step down by mid-2019, with the expectation that Atara will name a successor before June 30. Atara saw huge ups and downs in 2018, nearly tripling in value during the first five months of the year but then falling more than 40% between May and December. Many still see plenty of promise for the company's allogeneic cell therapies, but as the market environment turns hostile, shareholders don't seem convinced that Atara will see its stock price bounce back in 2019.

Skyworks deals with lower smartphone sales

Finally, shares of Skyworks Solutions closed lower by nearly 11%. The maker of internet network connectivity chips for smartphones was just one of many companies that fell sharply on news that sales of iPhones would likely come in well below what most investors were expecting to see. Skyworks has been tied to the fortunes of the smartphone market for a long time, and even though it's worked hard to diversify its exposure to include connectivity in autos, wearable devices, and smart-home applications, it still has a long way to go before it can shrug off smartphone weakness completely.

Check out the latest Skyworks earnings call transcript.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Skyworks Solutions, Inc. Stock Quote
Skyworks Solutions, Inc.
$152.09 (1.80%) $2.69
Delta Air Lines, Inc. Stock Quote
Delta Air Lines, Inc.
$38.68 (7.50%) $2.70
Atara Biotherapeutics, Inc. Stock Quote
Atara Biotherapeutics, Inc.
$16.95 (-0.82%) $0.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/06/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.